Legend Biotech Corp - ADR

NASDAQ:LEGN   3:59:53 PM EDT
54.45
-0.17 (-0.31%)
Earnings Announcements

Legend Biotech Reports Fourth Quarter And Full Year 2020 Results

Published: 03/18/2021 11:23 GMT
Legend Biotech Corp - ADR (LEGN) - Legend Biotech Reports Fourth Quarter and Full Year 2020 Financial Results and Business Update.
Q4 Loss per Share $0.22.
Q4 Earnings per Share Estimate $-0.28 -- Refinitiv Ibes Data (analyst estimates).
Q4 Revenue $40.8 Million Versus $19.5 Million.
Cash and Cash Equivalents and Time Deposits of $505.7 Million As of December 31, 2020.
Revenue is expected to be $7.83 Million
Adjusted EPS is expected to be -$0.44

Next Quarter Revenue Guidance is expected to be $81.83 Million
Next Quarter EPS Guidance is expected to be -$0.09

More details on our Analysts Page.